Full View

Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial

R Galea, F De Marco, N Meneveau, A Aminian… - Circulation, 2022 - Am Heart Assoc
Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …
被引用次数：92 相关文章

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

R Galea, MD Federico De Marco, N Meneveau… - Circulation, 2022 - Am Heart Assoc
BACKGROUND: No study has so far compared Amulet with the new Watchman FLX in terms
of residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

R Galea, F De Marco, N Meneveau, A Aminian… - 2022 - documentserver.uhasselt.be
BACKGROUND: No study has so far compared Amulet with the new Watchman FLX in terms
of residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.

R Galea, F De Marco, N Meneveau, A Aminian… - Circulation, 2021 - europepmc.org
Background No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.

R Galea, F De Marco, N Meneveau, A Aminian… - Circulation, 2022 - boris.unibe.ch
Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

A vs Watchman - Circulation, 2022 - m.chiba-u.ac.jp
Background: 経皮的左心耳閉鎖術を施行した患者における, 左心耳の残存間存率もしくは臨床的
転帰に関して, Amulet と Watchman FLX を比較した報告はない. Methods: 欧州の 8 …

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

R Galea, F De Marco, N Meneveau, A Aminian… - …, 2022 - ingentaconnect.com
Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

R Galea, F De Marco, N Meneveau, A Aminian… - 2022 - pubmed.ncbi.nlm.nih.gov
Background No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …
[PDF] archive.org

[PDF][PDF] Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial

R Galea, MD Federico De Marco, N Meneveau… - Circulation, 2022 - scholar.archive.org
BACKGROUND: No study has so far compared Amulet with the new Watchman FLX in terms
of residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …